ArticleExperimental & molecular medicine2026
A chronic whole cigarette smoke extract model reveals redox-mitochondrial adaptation in human lung epithelial and organoid models.
Article in Experimental & molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
15 authors.
Funding
Abstract
Cigarette smoke (CS) imposes continuous oxidative and electrophilic stress that disrupts cellular homeostasis in the lung. While acute smoking exposure induces transient antioxidant responses, how the epithelial system adapts to chronic smoke remains poorly defined. Here we developed a chronic whole CS extract (WCSE) model that integrates both gaseous and particulate fractions to reproduce the complexity of long-term smoking exposure. Using bronchial epithelial cells and human lung organoids, we demonstrate that chronic WCSE exposure induces a coordinated redox-mitochondrial adaptation, supporting survival under persistent oxidative stress. Chronically exposed cells (T-B2B) exhibited reduced apoptosis, enhanced S-phase entry and fragmented but functionally preserved mitochondria characterized by a stable membrane potential and restrained reactive oxygen species accumulation. Whole-exome sequencing revealed oxidative mutational signatures in two-dimensional and organoid models, linking chronic oxidative adaptation with tobacco-associated genomic imprints. Mechanistically, NRF2 activity was sustained through post-translational stabilization and nuclear accumulation independent of KEAP1, accompanied by activated pAKT and suppressed pGSK3β activity. Human lung organoids recapitulated these adaptations, showing enlarged morphology, reduced apoptosis and nuclear NRF2 accumulation, consistent with a stress-tolerant, clonally persistent phenotype. Together, these findings establish a chronic WCSE platform that models early epithelial adaptation to CS and uncovers NRF2-dependent redox remodeling as a key mechanism of long-term survival in smoking-related pulmonary injury.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.